ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

HAEGARDA
Hereditary angioedema
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

HAEGARDA Rx

Generic Name and Formulations:
C1 esterase inhibitor (human) 2000 IU, 3000 IU; lyophilized pwd for SC inj after reconstitution; preservative-free.

Company:
CSL Behring, LLC

Therapeutic Use:

Indications for HAEGARDA:

Routine prophylaxis to prevent hereditary angioedema (HAE) attacks in adolescent and adult patients.

Adults and Children:

Rotate inj sites. Give by SC inj (eg, abdominal area, other SC sites). 60 IU/kg twice weekly (every 3 or 4 days).

Warnings/Precautions:

Discontinue and treat if severe hypersensitivity reactions occur. Have epinephrine inj available. Risk of thromboembolism events. Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Pregnancy. Nursing mothers.

Pharmacological Class:

C1 inhibitor.

Adverse Reactions:

Inj site reaction, hypersensitivity, nasopharyngitis, dizziness.

Note:

To report infections that may have been transmitted by Haegarda, call (866) 915-6958.

Generic Availability:

NO

How Supplied:

Single-use vial—1

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs